Appropriations Requests for : Versiti Blood Health, Inc.

1. Cosponsoring legislators:

No Cosponsors

Recipient Information

2. Intended legislatively directed spending item recipient:

Versiti Blood Health, Inc.

3. Physical address of legislatively directed spending item recipient and the intended location of the project or activity:

1036 Fuller Ave. NE, Grand Rapids, MI 49503

4. The recipient's employer identification number:

390807235

Funding Details

5. Requested amount of the legislatively directed spending item:

$500,000.00

6. What is the purpose and how does the legislatively directed spending item provide a public benefit that is an appropriate use of taxpayer money?

The requested funds will be used to construct a laboratory clean room in Grand Rapids to support cellular therapies for a large region of Michigan. Cellular therapies are essential treatments for organ transplant patients and various cancers. New CAR-T therapies, for example, are rapidly being approved for use each year, with a growing patient population now requiring them. Laboratory clean rooms are required to process the patient cells for these life-saving treatments. The ability to process, store, and prepare these lifesaving treatments is beyond the capability of all but few of the largest hospital systems. Versiti’s Grand Rapids-based lab remains one of only three in the state of Michigan equipped to provide these technologies and, importantly, the only lab available to western/northern Michigan hospitals. Without Versiti, patients outside of Detroit and Ann Arbor would not have meaningful access to cutting-edge cancer therapies. The addition of a clean room is needed to support the growing number of patients seeking these cellular therapies. The addition of the clean room will enable Versiti to support nearly 200 additional Michigan cancer patients.

7. Has the legislatively directed spending item previously received or been awarded any of the following types of funding in the past 5 years?

✓ Yes: State Funding

Amount received: $3,750,000.00

8. Estimated time frame for completion of the legislatively directed spending item project:

End of fiscal year 2027

Additional Information For Nonprofit Corporations

9. Is the recipient a nonprofit corporation?

Yes

4. Officers and active members on the board of directors:

Officers: Matt Anderson, Executive Vice President, Medical Sciences Institute & Chief Medical Officer; Brian Bautista, Executive Vice President & Chief Operating Officer Lynne Briggs, Vice President & Chief Information Officer; Jessica Drouillard, Vice President & Chief Quality Officer; Gretchen Jameson, Executive Vice President & Chief Marketing Officer; Colleen McCarthy, Vice President, Organ and Tissue; Chris Miskel, Chief Executive Officer; Brad Pietz, Executive Vice President & Chief Laboratory Officer; Bart Reuter, Executive Vice President & General Counsel/Chief Compliance Officer; Christine Sadowski, Chief of Staff & Vice President of Advancement; Derek Tyus, Executive Vice President & Chief Financial Officer; and Jim Weidner, Executive Vice President & Chief Human Resources Officer. Board of Directors: Alan Whaley, Chairman; Dale Kent, Vice Chairman; Coreen Dicus-Johnson, Secretary; Ron Miller, Treasurer; Nicholas Bauer; Dixon Benz, II; Fred Geilfuss, II; David Ginsburg, MD; Cecelia Gore; Michael Graft; Sherry Husa; Jacopo Leonardi; James McGill, MD; Chris Miskel; Molly Mulroy; Maggey Oplinger; John Shull; and Gregory Wesley.

Certification By Sponsoring Legislator

• "I certify that my immediate family members, legislative staff members, and I have no direct or indirect pecuniary interest in the requested legislatively directed spending item."
• "I certify that the intended recipient of this legislatively directed spending item is not a for-profit entity."
• "I certify that the information in this form is true to the best of my knowledge."

Senator Mark E Huizenga